Context Therapeutics Inc. (CNTX)

Endeavor Group Holdings Statistics

Total Valuation

CNTX has a market cap or net worth of $62.79 million. The enterprise value is -$20.56 million.

Market Cap	62.79M
Enterprise Value	-20.56M

Important Dates

The last earnings date was Wednesday, August 6, 2025, after market close.

Earnings Date	Aug 6, 2025
Ex-Dividend Date	n/a

Share Statistics

CNTX has 89.70 million shares outstanding. The number of shares has increased by 243.31% in one year.

Current Share Class	89.70M
Shares Outstanding	89.70M
Shares Change (YoY)	+243.31%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	1.39%
Owned by Institutions (%)	25.47%
Float	39.35M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.76
P/TBV Ratio	0.76
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 19.09, with a Debt / Equity ratio of 0.00.

Current Ratio	19.09
Quick Ratio	18.33
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -37.25% and return on invested capital (ROIC) is -26.04%.

Return on Equity (ROE)	-37.25%
Return on Assets (ROA)	-25.22%
Return on Invested Capital (ROIC)	-26.04%
Return on Capital Employed (ROCE)	-46.37%
Revenue Per Employee	n/a
Profits Per Employee	-$2.85M
Employee Count	12
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -70.71% in the last 52 weeks. The beta is 1.89, so CNTX's price volatility has been higher than the market average.

Beta (5Y)	1.89
52-Week Price Change	-70.71%
50-Day Moving Average	0.69
200-Day Moving Average	0.99
Relative Strength Index (RSI)	45.14
Average Volume (20 Days)	167,585

Short Selling Information

The latest short interest is 1.21 million, so 1.35% of the outstanding shares have been sold short.

Short Interest	1.21M
Short Previous Month	1.60M
Short % of Shares Out	1.35%
Short % of Float	3.07%
Short Ratio (days to cover)	6.19

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-38.30M
Pretax Income	-18.57M
Net Income	-34.21M
EBITDA	-38.29M
EBIT	-38.30M
Earnings Per Share (EPS)	-$0.39

Balance Sheet

The company has $83.52 million in cash and $167,319 in debt, giving a net cash position of $83.35 million or $0.93 per share.

Cash & Cash Equivalents	83.52M
Total Debt	167,319
Net Cash	83.35M
Net Cash Per Share	$0.93
Equity (Book Value)	82.54M
Book Value Per Share	0.92
Working Capital	82.39M

Cash Flow

In the last 12 months, operating cash flow was -$17.70 million and capital expenditures -$41,264, giving a free cash flow of -$17.74 million.

Operating Cash Flow	-17.70M
Capital Expenditures	-41,264
Free Cash Flow	-17.74M
FCF Per Share	-$0.20

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CNTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-243.31%
Shareholder Yield	-243.31%
Earnings Yield	-54.48%
FCF Yield	-28.26%

Analyst Forecast

The average price target for CNTX is $5.25, which is 650.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$5.25
Price Target Difference	650.00%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-40.55%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1